Latest News
GE Healthcare Contrast Media Products in Short Supply
Tirzepatide Superior to Placebo in Weight Loss Study
Hidden Drugs Found in Supplements Promoted for Musculoskeletal Conditions
Sexual Minority Students Perceive Medical School Less Favorably
Cigarette Smoking Down for Adults With Behavioral Health Conditions
Annual Costs Estimated for Wart Treatment in the U.S. for 2015-2017
Hypertensive Disorders of Pregnancy Prevalence Up From 2017 to 2019
Catheter Ablation vs Antiarrhythmic Drugs for Patients With ICD and Symptomatic VT
Advanced Heart Failure Stage Associated With Increased Risk of All-Cause Mortality
Pulmonary Hypertension Ups Kidney Graft Dysfunction Risk
FDA Panel Will Meet to Discuss Multiple COVID-19 Vaccine EUA Requests
Consider COVID Vaccination History When Assessing Adenopathy on Mammography
Vaccination Cuts Severe COVID-19 Risk in Heart Transplant Patients
Residential Green Space May Aid Cognition in Adult Women
Featured Content
Blueprint for Youth Suicide Prevention
With youth suicides on the rise, the American Academy of Pediatrics and American Foundation for Suicide Prevention, in collaboration with experts from the National Institute of Mental Health (NIMH), created a document to support pediatric health clinicians.
Stroke-Associated Pneumonia: Risk Factors, Mechanisms, and Interventions
Stroke-associated pneumonia research over the past 2 decades has yielded significant insight into SAP risk factors, diagnostic measures, and management strategies.
The “Weekend Effect” in Cardiac Emergency Outcomes
Saraschandra Vallabhajosyula, MD, and Ibrahim Sultan, MD, discuss the relationship between the weekend effect and poor prognosis following cardiac emergencies.
Gender Bias Common in Online Reviews of Physicians
Patients rated female doctors more on their interpersonal skills and not much on their technical competence, a study found.
It’s a Doctor’s Duty to Combat Misinformation
The COVID-19 pandemic has underscored how easy it is for disreputable and non-authoritative sources to spread wrong and possibly dangerous medical information.
We Run Clinical Trials for Medications, Why Not for Apps?
The author comments on the current situation where behavioral modification smartphone apps do not undergo any oversight such as safety or efficacy studies, nor do they go through the Institutional Review Board to guide or evaluate ethics.
- Loading...
Loading...
Loading... 
Loading...